Thalassemia Market Size, Share & Trends Analysis Report By Treatment (Iron Chelating Drugs, Erythroid Maturation Agents, Stem Cell Therapy), By Type (Alpha Thalassemia, Beta Thalassemia), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Tennis Racquet Market Growth & Trends
The global tennis racquet market size is expected to reach USD 690.7 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% over the forecast period. Rising importance of sports in maintaining body metabolism and improving muscular strength is expected to promote the use of tennis among health conscious adults. In addition, rising popularity of cardio tennis in developed countries including U.S., Germany, and France is projected to remain a key factor in the near future.
Carbon fiber accounted for more than 78.2% share of the global revenue in 2023. Features including lightweight, high strength, and high stiffness are fueling the demand for the product among core players as well as amateur. Producers also find it more convenient than wood, steel or aluminum based product, as carbon fiber allows to distribute stiffness as per the customized requirements.
Professional players segment accounted for the largest market revenue share in 2023. Increasing number of professional lawn tennis tournaments in countries including Indonesia, India, and Australia as a result of increasing funding of domestic sports authorities to provide the exposure of international medium to the national youth players is expected to open new avenues in the near future.
In April 2015, ABG-PRINCE OPCO, LLC has launched a new product line of TeXtreme carbon fiber material. This product is 20% lighter, along with better stiffness. It is available in different frames including Tour 100T, Tour 95, Warrior 107T, and Warrior 107. Similarly, in November 2018, Babolat partnered with Chomarat, a supplier of multiaxial carbon. Babolat will be using Chomarat’s C-PLY Hexagonal for the production of its Pure Aero racket.
Key competitors of the tennis racquets industry include Amer Sports, YONEX Co., Ltd., Dunlop Sports, Babolat, Head N.V., ASI LLC, Tecnifibre, GAMMA Sports, Pacific Holdings Limited, ProKennex, Slazenger, ABG-PRINCE OPCO, LLC, Solinco, and PowerAngle LLC.
Tennis Racquet Market Report Highlights
Tennis Racquet Market Growth & Trends
The global tennis racquet market size is expected to reach USD 690.7 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% over the forecast period. Rising importance of sports in maintaining body metabolism and improving muscular strength is expected to promote the use of tennis among health conscious adults. In addition, rising popularity of cardio tennis in developed countries including U.S., Germany, and France is projected to remain a key factor in the near future.
Carbon fiber accounted for more than 78.2% share of the global revenue in 2023. Features including lightweight, high strength, and high stiffness are fueling the demand for the product among core players as well as amateur. Producers also find it more convenient than wood, steel or aluminum based product, as carbon fiber allows to distribute stiffness as per the customized requirements.
Professional players segment accounted for the largest market revenue share in 2023. Increasing number of professional lawn tennis tournaments in countries including Indonesia, India, and Australia as a result of increasing funding of domestic sports authorities to provide the exposure of international medium to the national youth players is expected to open new avenues in the near future.
In April 2015, ABG-PRINCE OPCO, LLC has launched a new product line of TeXtreme carbon fiber material. This product is 20% lighter, along with better stiffness. It is available in different frames including Tour 100T, Tour 95, Warrior 107T, and Warrior 107. Similarly, in November 2018, Babolat partnered with Chomarat, a supplier of multiaxial carbon. Babolat will be using Chomarat’s C-PLY Hexagonal for the production of its Pure Aero racket.
Key competitors of the tennis racquets industry include Amer Sports, YONEX Co., Ltd., Dunlop Sports, Babolat, Head N.V., ASI LLC, Tecnifibre, GAMMA Sports, Pacific Holdings Limited, ProKennex, Slazenger, ABG-PRINCE OPCO, LLC, Solinco, and PowerAngle LLC.
Tennis Racquet Market Report Highlights
- The North America dominated the tennis racquet market in 2023 with a revenue share of 33.2%.
- Asia Pacific is expected to expand at the fastest CAGR in terms of revenue from 2024 to 2030
- By material, the aluminum segment is expected to witness significant growth over the forecast period. Aluminum racquets are less expensive, making them an attractive option for budget-conscious consumers.
- The online segment is anticipated to register a significant CAGR over the forecast period. Online shopping allows consumers to browse and purchase products from the comfort of their homes, eliminating the need for physical store visits.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. THALASSEMIA MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Thalassemia Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. THALASSEMIA MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Thalassemia Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
4.3. Iron Chelating Drugs
4.3.1. Iron Chelating Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Erythyroid Maturation Agents
4.4.1. Erythyroid Maturation Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Stem Cell therapy
4.5.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. THALASSEMIA MARKET: TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Thalassemia Market: Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Alpha Thalassemia
5.3.1. Alpha Thalassemia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Beta Thalassemia
5.4.1. Beta Thalassemia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. THALASSEMIA MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Thalassemia Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK.
6.3.2.1. UK Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CHIESI Farmaceutici S.p.A.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Bristol-Myers Squibb Company
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Sun Pharmaceutical Industries Ltd.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Cipla
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Fresenius Kabi AG
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Novartis Pharmaceuticals Corporation
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Apotex Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. bluebird bio, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. THALASSEMIA MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Thalassemia Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. THALASSEMIA MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Thalassemia Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
4.3. Iron Chelating Drugs
4.3.1. Iron Chelating Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Erythyroid Maturation Agents
4.4.1. Erythyroid Maturation Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Stem Cell therapy
4.5.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. THALASSEMIA MARKET: TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Thalassemia Market: Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Alpha Thalassemia
5.3.1. Alpha Thalassemia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Beta Thalassemia
5.4.1. Beta Thalassemia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. THALASSEMIA MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Thalassemia Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK.
6.3.2.1. UK Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. China Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. South Korea Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Thalassemia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CHIESI Farmaceutici S.p.A.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Bristol-Myers Squibb Company
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Sun Pharmaceutical Industries Ltd.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Cipla
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Fresenius Kabi AG
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Novartis Pharmaceuticals Corporation
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Apotex Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. bluebird bio, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
